FDA also authorised the FoundationOne®CDx assay like a companion diagnostic device to recognize people with breast cancer for treatment method with capivasertib with fulvestrant. CAPIVASERTIB (kap EYE va SER tib) treats breast most cancers. It works by blocking a protein that causes cancer cells to develop and multiply. This helps https://ericw000isd2.blog5star.com/profile